Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Andrew Armstrong, MD, ScM
Woman and Man Max 99 years
Andrew Armstrong, MD, ScM
Update Il y a 5 ans
Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
To compare the anti-tumor activity of everolimus and sunitinib in subjects with metastatic renal cell carcinoma (mRCC) with non-clear cell pathology.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD, ScM
Update Il y a 5 ans
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer
This is a single arm study of 11 men with treatment refractory metastatic Castrate Resistant Prostate Cancer (CRPC) who will receive temsirolimus IV at a dose of 25 mg weekly until progres...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Andrew Armstrong, MD, ScM
Update Il y a 5 ans
BKM120 in Metastatic Castration-resistant Prostate Cancer
The purpose of this study is to evaluate the effects of the study drug, BKM120. The study drug, BKM120, is an inhibitor of a protein called phosphatidyl inositol-3-kinase (PI3K). This prot...
Country
None
organs
None
Specialty
None
Closed trial
More information